Efficacy and Safety of Moderate-Intensity Continuous Training on the Improvement of Cardiopulmonary Function in Patients After Transcatheter Aortic Valve Replacement (ENERGY): A Randomized Controlled Trial
Overview
Authors
Affiliations
Objectives: To investigate the effect of moderate-intensity continuous training (MICT) on the improvement of cardiopulmonary function for patients undergoing transcatheter aortic valve replacement (TAVR).
Design: Randomized controlled study.
Setting And Participants: Between August 20, 2021, and February 28, 2022, a total of 66 patients after TAVR were screened for inclusion and randomly divided into the MICT and control groups at a ratio of 1:1. MICT was scheduled 3 times per week for 3 months in the intervention group. Patients in the control group received one-time advice on physical activity according to the current guideline.
Methods: The primary endpoint was the 3-month change in peak oxygen consumption (peak VO) assessed by cardiopulmonary exercise testing. The secondary endpoints included the 3-month change in 6-minute walk test (6MWT), the 12-Item Short Form Health Survey (SF-12), New York Heart Association (NYHA) class, echocardiographic parameters, and laboratory parameters.
Results: After 3 months, the change in peak VO was higher in the MICT group than that in the control group (1.63 mL/kg/min, 95% CI 0.58-2.67, P = .003). Change in 6MWT (21.55 m, 95% CI 0.38-42.71, P = .046) was higher in the MICT group compared with the control group. A significant change in favor of MICT was also observed for low-density lipoprotein cholesterol (-0.62 mmol/L, 95% CI -1.00 to -0.23, P = .002). However, there were no significant changes in other echocardiographic indices, laboratory parameters, and SF-12 between the 2 groups (all P > .05).
Conclusions And Implications: MICT had a positive effect on the cardiopulmonary function and physical capacity of patients after TAVR.
Wu C, Chen X, Yang L, Sun H, Bao S, Li H Expert Rev Mol Med. 2024; 27():e2.
PMID: 39567354 PMC: 11707833. DOI: 10.1017/erm.2024.25.
Chin K, Jones R, Lester E, Hegarty A, Thielemans L, Schiff R Eur Geriatr Med. 2024; 15(6):1615-1630.
PMID: 39327412 PMC: 11631815. DOI: 10.1007/s41999-024-01035-5.
Shen Z, Mi S, Huang C, Zhou D, Pan W, Xu X BMJ Open. 2024; 14(3):e080042.
PMID: 38453208 PMC: 10921510. DOI: 10.1136/bmjopen-2023-080042.
Hosseinpour A, Azami P, Hosseinpour H, Attar A, Koushkie Jahromi M Int J Cardiol Cardiovasc Risk Prev. 2024; 20:200238.
PMID: 38322761 PMC: 10844670. DOI: 10.1016/j.ijcrp.2024.200238.
Zou J, Yuan J, Liu J, Geng Q Front Cardiovasc Med. 2023; 10:1164104.
PMID: 38152609 PMC: 10751363. DOI: 10.3389/fcvm.2023.1164104.